Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for treatment of HIV/HCV co-infected patients-Reference-Cited by-同舟云学术

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for treatment of HIV/HCV co-infected patients

Published:2004-09 Issue:13 Volume:18 Page:27-36
ISSN:0269-9370
Container-title:AIDS
language:en
Short-container-title:AIDS

Author:

Laguno Montserrat,Murillas Javier,Blanco José Luis,Martínez Esteban,Miquel Rosa,Sánchez-Tapias José M,Bargallo Xavier,García-Criado Angeles,Lazzari Elisa de,Larrousse María,León Agathe,Loncá Montserrat,Milinkovic Ana,Gatell Josep M,Mallolas Josep

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference20 articles.

1. Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus Infection

2. Hepatitis C in the HIV-Infected Person

3. Correlates of Hepatitis C Virus Infections among Injection Drug Users

4. Increasing Mortality Due to End-Stage Liver Disease in Patients with Human Immunodeficiency Virus Infection

5. Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients

Cited by 332 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Construction of a piezoelectric immunosensor for ultra-sensitive and highly selective detection of ribavirin in animal-derived foods;Analytical Methods;2022

2. Polypharmacology in Clinical Applications: Anti-infection Polypharmacology;Polypharmacology;2022

3. Well tolerability and highly effective treatment response for hepatitis C virus-human immunodeficiency virus–coinfected patients treated by all-oral direct-acting antivirals;Journal of the Chinese Medical Association;2021-04-30

4. People with HIV-1 Demonstrate Type 1 Interferon Refractoriness Associated with Upregulated USP18;Journal of Virology;2021-03-03

5. Therapeutic drugs for SARS-CoV-2 treatment: Current state and perspective;International Immunopharmacology;2021-01